The analysis notes that drug resistance is becoming more of an issue across the entire infection control continuum. Patients, third party payers and tax payers, through Medicare and Medicaid payments, shoulder the added expense of hospital infections, which is an estimated $35 billion to $40 billion in costs each year in the U.S.
The U.S. provided more than $11 million in state funding for HAI prevention infrastructure projects and development in 2013, according to the report.
More articles on quality:
Study: Bloodstream infection-causing bacteria increasingly resistant to common antiseptic
Hand hygiene or environmental cleaning: Which is more effective?
Research identifies predictors of COPD patient early readmission
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
